Malaria News and Research

Latest Malaria News and Research

Gold-containing drug auranofin kills 95% of SARS-CoV-2 virus in 48 hours in lab conditions

A drug called auranofin, approved for the treatment of rheumatoid arthritis, effectively inhibits severe acute respiratory syndrome coronavirus (SARS-CoV-2) in laboratory conditions, as described in a new study by Georgia State University researchers.

16 Apr 2020

Researchers decode how immune sensor plays role in defending cells against intruders

Until now, the immune sensor TLR8 has remained in the shadows of science. A research team led by the University of Bonn has now discovered how this sensor plays an important role in defending human cells against intruders.

15 Apr 2020

Study shows possible way to effectively deliver RNA drugs to tumors

In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes, have become promising drug candidates in several areas.

15 Apr 2020

Cost of ‘repurposing’ existing drugs to treat COVID-19

The paper looks at repurposed drugs that might demonstrate efficacy against COVID-19, and if they could be manufactured profitably at very low costs to ensure affordable access to vital treatments for COVID-19 at low prices globally.

13 Apr 2020

Study looks into how malaria parasite evades the immune system

The parasite causing the most severe form of human malaria uses proteins to make red blood cells sticky, making it harder for the immune system to destroy it and leading to potentially fatal blood clots. New research at the Crick has identified how the parasite may control this process.

13 Apr 2020

Clinical trial to investigate effectiveness of antimalarial drugs for COVID-19 treatment

Washington University School of Medicine in St. Louis is launching a clinical trial for patients hospitalized with COVID-19 at Barnes-Jewish Hospital.

9 Apr 2020

‘You pray that you got the drug.’ Ailing couple gambles on trial for COVID-19 cure

For 10 days last month, they lay in side-by-side isolation units in a Seattle-area hospital, tethered to oxygen and struggling to breathe as the coronavirus ravaged their lungs.

6 Apr 2020

Using marine natural product to inhibit cervical cancer

A sponge found in Manado Bay, Indonesia, makes a molecule called manzamine A, which stops the growth of cervical cancer cells, according to a recent publication in the Journal of Natural Products submitted by researchers at the Medical University of South Carolina and their collaborators.

6 Apr 2020

St George's, University of London focuses entire research on tackling coronavirus

St George's, University of London, the UK's specialist health university, is focusing all its ongoing research on tackling coronavirus.

3 Apr 2020

Who should be taking antimalarial drugs as treatment against COVID-19?

Researchers provide a guideline regarding who should be actually taking antimalarial drugs as prophylaxis to prevent getting COVID-19. They say health professionals who are being exposed to COVID-19 positive patients and those who test positive but are asymptomatic should be taking drugs such as Chloroquine and Hydroxychloroquine. They explain that these populations remain most in need, and because of limited supply, these individuals need to be prioritized.

2 Apr 2020

Drugs considered for COVID-19 can increase risk for dangerous arrhythmias

As some consider treating coronavirus patients with a combination of the malaria drug hydroxychloroquine and the antibiotic azithromycin, cardiologists are advising caution because both medications can increase the risk for dangerous abnormal heart rhythms.

2 Apr 2020

Penn State engineer developing point-of-care testing device to diagnose COVID-19

A point-of-care testing device that may help diagnose the novel coronavirus disease (COVID-19) is under development by Weihua Guan, assistant professor of electrical engineering in Penn State's College of Engineering.

2 Apr 2020

FDA to trial malaria drugs Chloroquine and Hydroxychloroquine for COVID-19

The U.S. Food and Drug Administration (FDA) this week provided the necessary authorization for clinical trials of chloroquine and hydroxychloroquine for the treatment of the novel coronavirus. These two drugs have been claimed by President Donald Trump to be a potential treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes COVID-19 disease. To date, there has been no conclusive proof regarding the safety and efficacy of these drugs in COVID-19 cases, say officials.

31 Mar 2020

Fast-acting anti-malarial compound shows promise in first clinical trial

A fast-acting anti-malarial compound discovered at St. Jude Children's Research Hospital was well tolerated and showed promising anti-malarial effects in the first study in humans.

27 Mar 2020

New research initiative to investigate multi-species response to novel coronavirus

Scientists at Texas Biomedical Research Institute (Texas Biomed) today announced the launch of a comprehensive research initiative to investigate multiple animal species and their response to the novel coronavirus disease (COVID-19).

26 Mar 2020

Critical guidance to identify COVID-19 patients at risk of drug-induced sudden cardiac death

SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 vaccine, but it's still likely 12 to 18 months away.

25 Mar 2020

Why hoarding of hydroxychloroquine needs to stop

A family of old antimalarial drugs — including one that some patients rely on to treat their lupus or rheumatoid arthritis — is becoming harder to get in the United States, pharmacists say, partly because of remarks President Donald Trump has made, highlighting the drugs as a potential treatment for COVID-19.

25 Mar 2020

Huge WHO trial of COVID-19 therapies begins

As the world reels from the devastating impact and the looming threat of the novel coronavirus COVID-19, researchers around the globe are racing to find a cure that will reduce symptom severity and reverse the course of the disease, freeing up more hospital space and making it possible to treat more of the severely affected cases.

24 Mar 2020

DFG underlines the need for long-term, knowledge-driven basic research

In view of the coronavirus pandemic, the Deutsche Forschungsgemeinschaft has underlined the need for long-term, knowledge-driven basic research.

21 Mar 2020

Researchers highlight urgent need for public health leadership during COVID-19 pandemic

For decades, public health officials have directed the containment of emerging pandemics - perhaps most notably - the worldwide eradication of smallpox starting in the early to mid-1960s.

19 Mar 2020

Malaria News and Research

Latest Malaria News and Research

Gold-containing drug auranofin kills 95% of SARS-CoV-2 virus in 48 hours in lab conditions

Researchers decode how immune sensor plays role in defending cells against intruders

Study shows possible way to effectively deliver RNA drugs to tumors

Cost of ‘repurposing’ existing drugs to treat COVID-19

Study looks into how malaria parasite evades the immune system

Clinical trial to investigate effectiveness of antimalarial drugs for COVID-19 treatment

‘You pray that you got the drug.’ Ailing couple gambles on trial for COVID-19 cure

Using marine natural product to inhibit cervical cancer

St George's, University of London focuses entire research on tackling coronavirus

Who should be taking antimalarial drugs as treatment against COVID-19?

Drugs considered for COVID-19 can increase risk for dangerous arrhythmias

Penn State engineer developing point-of-care testing device to diagnose COVID-19

FDA to trial malaria drugs Chloroquine and Hydroxychloroquine for COVID-19

Fast-acting anti-malarial compound shows promise in first clinical trial

New research initiative to investigate multi-species response to novel coronavirus

Critical guidance to identify COVID-19 patients at risk of drug-induced sudden cardiac death

Why hoarding of hydroxychloroquine needs to stop

Huge WHO trial of COVID-19 therapies begins

DFG underlines the need for long-term, knowledge-driven basic research

Researchers highlight urgent need for public health leadership during COVID-19 pandemic

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in